Broadfin Capital, Kevin Kotler Disclose a 5.7% Stake in Discovery Laboratories

Broadfin Capital, Discovery Laboratories: In a new 13G filing just reported to the SEC, Broadfin Capital, managed by Kevin Kotler, disclosed a 5.77% stake in small-cap biotech Discovery Laboratories, Inc. (NASDAQ:DSCO).